| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
|
Zhang, L.
|
|
2019
|
21 |
8 |
p. 1052-1060
|
article
|
| 2 |
Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona
|
Ameijide, A.
|
|
2018
|
21 |
8 |
p. 1014-1025
|
article
|
| 3 |
Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma
|
Feng, L. X.
|
|
2019
|
21 |
8 |
p. 1005-1013
|
article
|
| 4 |
Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
|
Carmona-Bayonas, A.
|
|
2019
|
21 |
8 |
p. 1112-1114
|
article
|
| 5 |
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
|
Moya-Alarcón, Carlota
|
|
2019
|
21 |
8 |
p. 1076-1084
|
article
|
| 6 |
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
|
Barth, D. A.
|
|
2019
|
21 |
8 |
p. 1034-1043
|
article
|
| 7 |
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
|
Amraee, A.
|
|
|
21 |
8 |
p. 1093-1103
|
article
|
| 8 |
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
|
Amraee, A.
|
|
2019
|
21 |
8 |
p. 1093-1103
|
article
|
| 9 |
Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma
|
Viñal, D.
|
|
2019
|
21 |
8 |
p. 1061-1066
|
article
|
| 10 |
Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery
|
Li, F.
|
|
2019
|
21 |
8 |
p. 1067-1075
|
article
|
| 11 |
Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study
|
Calderon, C.
|
|
2019
|
21 |
8 |
p. 1104-1107
|
article
|
| 12 |
Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1
|
Wang, Y.
|
|
2019
|
21 |
8 |
p. 1026-1033
|
article
|
| 13 |
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohorts
|
Westphalen, C. B.
|
|
2019
|
21 |
8 |
p. 1108-1111
|
article
|
| 14 |
Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study
|
Si, P.
|
|
2019
|
21 |
8 |
p. 1085-1092
|
article
|
| 15 |
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
|
González-San Segundo, C.
|
|
2019
|
21 |
8 |
p. 1044-1051
|
article
|
| 16 |
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
|
Peters, S.
|
|
2019
|
21 |
8 |
p. 977-991
|
article
|
| 17 |
The role of immunotherapy in small cell lung cancer
|
Calles, A.
|
|
2019
|
21 |
8 |
p. 961-976
|
article
|
| 18 |
Time for radioimmunotherapy: an overview to bring improvements in clinical practice
|
Leaman Alcibar, O.
|
|
2019
|
21 |
8 |
p. 992-1004
|
article
|
Journal description